Insider trades
Phillip G. Febbo, Chief Officer of Veracyte VCYT, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $786.2K. The latest trade was on 06/02.
Phillip G. Febbo
Chief Scientific & Med Officer
- Company
- Veracyte VCYT
- First filing
- 23/02/23
- Trades
- 28 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$786.2K
- Last trade
- 06/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
VeracyteVCYT | Open-market sale10b5-1 plan | 03/02 | 03/04 | 13,425 sh | $36.16 | $485,448 | −10.3% |
VeracyteVCYT | Open-market sale10b5-1 plan | 25/10/06 | 25/10/07 | 8,349 sh | $36.02 | $300,730.98 | −8.3% |
VCYT | Open-market sale10b5-1 plan | 25/03/04 | 25/03/06 | 8,037 sh2 trades | $33.34avg. | $267,987.12 | −8.9% |
VeracyteVCYT | Open-market sale10b5-1 plan | 24/12/04 | 24/12/06 | 3,934 sh | $44.09 | $173,450.06 | −4.6% |